In recognition of National Breast Cancer Awareness Month, the October edition of the roundup features articles on breast cancer treatments, prevention, testing, and impact.
Have a perspective on one of these stories? Submit your post to the AAPS Blog!
FDA Grants Priority Review for Pfizer’s HER2- Advanced Breast Cancer Treatment, by Ashley Roberts, PharmTech, October 14, 2014
‘Gene deserts’ are linked with breast cancer, research suggests, The Pharmaceutical Journal, October 8, 2014
Breast cancer drug sales will almost double by 2023, says IMS, by Lynne Taylor, PharmaTimes, October 2, 2014
A Therapeutic Microparticle-Based Tumor Lysate Vaccine Reduces Spontaneous Metastases in Murine Breast Cancer, by Brett P. Gross, Amaraporn Wongrakpanich, Meghan B. Francis, Aliasger K. Salem, Lyse A. Norian, The AAPS Journal, September 16, 2014
The (Unmet) Potential Value of Cancer Genome Testing, by Elaine Schattner, Forbes, September 24, 2014
Testing for Cancer With a Single Blood Sample, by Corinne Iozzio, Smithsonian.com, October 20, 2014
Targeting Cell Cycle Progression: CDK4/6 Inhibition in Breast Cancer, by Sneha Phadke, D.O., and Alexandra Thomas, M.D., OncLive, October 3, 2014
Hormone Active During Day Supresses Growth of Cancer Cells, Study, by Stephen Adkins, University Herald, October 17, 2014